Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Sydney Institute for Women, Children and their Families, Sydney Local Health District, Sydney, New South Wales, Australia.
Aust N Z J Obstet Gynaecol. 2023 Aug;63(4):599-602. doi: 10.1111/ajo.13700. Epub 2023 May 18.
Uterine transplantation (UT) is an emerging medical treatment for women affected by absolute uterine factor infertility (AUFI). To date there have been over 90 documented cases of UT performed worldwide, with over 50 live births. UT allows women affected by AUFI the opportunity to carry and deliver a childd. The Royal Prince Alfred Hospital (RPAH) introduced a UT study in 2019; however, due to the impacts of the COVID pandemic the study was placed on hold for two years. In February 2023, RPAH performed the centre's first UT from a living unrelated donor to a 25-year-old woman with Mayer-Rokitansky-Küster-Hauser syndrome. The donor and recipient surgeries were uncomplicated and both are recovering well in the early post-operative period.
子宫移植（UT）是一种新兴的医学治疗方法，适用于患有绝对子宫因素不孕（AUFI）的女性。迄今为止，全球已有超过 90 例 UT 手术的记录，其中超过 50 例活产。UT 使患有 AUFI 的女性有机会怀孕和分娩。皇家阿尔弗雷德王子医院（RPAH）于 2019 年开展了 UT 研究；然而，由于 COVID 大流行的影响，该研究暂停了两年。2023 年 2 月，RPAH 为一名 25 岁的患有 Mayer-Rokitansky-Küster-Hauser 综合征的女性进行了中心首例来自活体无关供体的 UT。供体和受体手术均顺利，术后早期均恢复良好。
